Sanctuary et al., 2019 - Google Patents
Pilot study of probiotic/colostrum supplementation on gut function in children with autism and gastrointestinal symptomsSanctuary et al., 2019
View HTML- Document ID
- 17559308878902505646
- Author
- Sanctuary M
- Kain J
- Chen S
- Kalanetra K
- Lemay D
- Rose D
- Yang H
- Tancredi D
- German J
- Slupsky C
- Ashwood P
- Mills D
- Smilowitz J
- Angkustsiri K
- Publication year
- Publication venue
- PloS one
External Links
Snippet
Over half of all children with autism spectrum disorders (ASD) have gastrointestinal (GI) co- morbidities including chronic constipation, diarrhea, and irritable bowel syndrome. The severity of these symptoms has been correlated with the degree of GI microbial dysbiosis …
- 230000002496 gastric 0 title abstract description 96
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sanctuary et al. | Pilot study of probiotic/colostrum supplementation on gut function in children with autism and gastrointestinal symptoms | |
| Durack et al. | Delayed gut microbiota development in high-risk for asthma infants is temporarily modifiable by Lactobacillus supplementation | |
| Moubareck | Human milk microbiota and oligosaccharides: a glimpse into benefits, diversity, and correlations | |
| Stiemsma et al. | The role of the microbiome in the developmental origins of health and disease | |
| Vitellio et al. | Effects of Bifidobacterium longum and Lactobacillus rhamnosus on gut microbiota in patients with lactose intolerance and persisting functional gastrointestinal symptoms: A randomised, double-blind, cross-over study | |
| Mills et al. | Precision nutrition and the microbiome part II: potential opportunities and pathways to commercialisation | |
| Bear et al. | The microbiome-gut-brain axis and resilience to developing anxiety or depression under stress | |
| Baldassarre et al. | Rationale of probiotic supplementation during pregnancy and neonatal period | |
| West et al. | Probiotics during weaning reduce the incidence of eczema | |
| Navarro et al. | Can probiotics benefit children with autism spectrum disorders? | |
| Mokkala et al. | Metagenomics analysis of gut microbiota in response to diet intervention and gestational diabetes in overweight and obese women: a randomised, double-blind, placebo-controlled clinical trial | |
| Aitoro et al. | Gut microbiota as a target for preventive and therapeutic intervention against food allergy | |
| Jiang et al. | Gut microbiota may play a significant role in the pathogenesis of Graves' disease | |
| Whelan et al. | Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease | |
| Boyle et al. | Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial | |
| Krishnareddy | The microbiome in celiac disease | |
| Gosalbes et al. | Meconium microbiota types dominated by lactic acid or enteric bacteria are differentially associated with maternal eczema and respiratory problems in infants | |
| Taylor et al. | Effects of probiotic supplementation for the first 6 months of life on allergen‐and vaccine‐specific immune responses | |
| Zaidi et al. | Impact of maternal nutritional supplementation during pregnancy and lactation on the infant gut or breastmilk microbiota: a systematic review | |
| Rutten et al. | Long term development of gut microbiota composition in atopic children: impact of probiotics | |
| Guillemard et al. | Effects of consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 on common respiratory and gastrointestinal infections in shift workers in a randomized controlled trial | |
| Dogra et al. | Nurturing the early life gut microbiome and immune maturation for long term health | |
| Hibberd et al. | No evidence of harms of probiotic Lactobacillus rhamnosus GG ATCC 53103 in healthy elderly—a phase I open label study to assess safety, tolerability and cytokine responses | |
| Horvath et al. | The effects of a multispecies synbiotic on microbiome-related side effects of long-term proton pump inhibitor use: A pilot study | |
| Natividad et al. | Human milk oligosaccharides and lactose differentially affect infant gut microbiota and intestinal barrier in vitro |